CAndesartan vs LIsinopril Effects on the BRain and Endothelial Function in eXecutive MCI

Trial Profile

CAndesartan vs LIsinopril Effects on the BRain and Endothelial Function in eXecutive MCI

Recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Mar 2017

At a glance

  • Drugs Candesartan cilexetil (Primary) ; Lisinopril
  • Indications Hypertension
  • Focus Pharmacodynamics
  • Acronyms CALIBREX
  • Most Recent Events

    • 09 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 06 May 2014 Planned initiation date changed from 1 Feb 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.
    • 25 Nov 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top